Author

D. Mallery

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 2 Assay:proteomics· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Albecka· 2 shared G. Papa· 2 shared J. Luptak· 2 shared L. C. James· 2 shared L. James· 2 shared R. Doffinger· 2 shared A. Abdullahi· 1 shared A. P. Carter· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. Albecka

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

TRIM7 restricts Coxsackievirus and norovirus infection by detecting the C-terminalglutamine generated by 3C protease processing

J. Luptak, D. Mallery, A. S. Jahun, A. Albecka, D. Clift, O. Ather, G. Slodkowicz, I. Goodfellow, L. James

The paper identifies TRIM7 as a viral restriction factor that recognizes a conserved C-terminal glutamine motif generated by viral proteases, inhibiting Coxsackie and norovirus replication.

bioRxiv · Jun 28, 2022Biochemistry

SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion

B. Meng, I. Ferreira, A. Abdullahi, N. Goonawardane, A. Saito, I. Kimura, D. Yamasoba, S. A. Kemp, G. Papa, S. Fatihi, S. Rathore, P. Perera Gerba, T. Ikeda, M. Toyoda, T. S. Tan, , S. Zepeda

This study investigates the immune escape, infectivity, and cell-cell fusion properties of SARS-CoV-2 Omicron BA.1 compared to Delta, showing higher ACE2 affinity and antibody evasion but similar antiviral drug efficacy.

bioRxiv · Dec 17, 2021Microbiology

SARS-CoV-2 spike protein arrested in the closed state induces potent neutralizing responses

G. W. Carnell, K. A. Ciazynska, D. A. Wells, X. Xiong, E. T. Aguinam, S. H. McLaughlin, D. Mallery, S. Ebrahimi, L. Ceron-Gutierrez, L. C. James, R. Doffinger, J. L. Heeney, J. A. G. Briggs

This study evaluates closed-state SARS-CoV-2 spike protein immunization in mice, finding it induces potent neutralizing antibodies and T-cell responses, with unique binding properties compared to standard S protein constructs.

bioRxiv · Jan 14, 2021Immunology

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

G. Papa, D. Mallery, A. Albecka, L. Welch, J. Cattin-Ortola, J. Luptak, D. Paul, H. T. McMahon, I. G. Goodfellow, A. P. Carter, S. Munro, L. C. James

bioRxiv · Aug 13, 2020Microbiology